Boya Bio-Pharmaceutical Group is Biotechnology in China that focus on Group Co Ltd business. Founded in 1993. They cover business area such as Boya Bio-Pharmaceutical Group Co Ltd, biochemical drug, active pharmaceutical ingredient, medical and health product, service, blood product, chemical medicine, human albumin, rabie immunoglobulin, intravenous human immunoglobulin, human fibrinogen.
1993
( 31 years old in 2024 )
Group Co Ltd
-
No.333, Huiquan Road
High-tech Industrial Park
Fuzhou, Jiangxi 344000
China
Private
Boya Bio-Pharmaceutical Group Co Ltdbiochemical drugactive pharmaceutical ingredientmedical and health productserviceblood productchemical medicinehuman albuminrabie immunoglobulinintravenous human immunoglobulinhuman fibrinogen
* We use standard office opening hours in near Boya Bio-Pharmaceutical Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Boya Bio-Pharmaceutical Group is Biotechnology business from China that founded in 1993 (31 years old in 2024), Boya Bio-Pharmaceutical Group business is focusing on Group Co Ltd.
Boya Bio-Pharmaceutical Group headquarter office and corporate office address is located in No.333, Huiquan Road High-tech Industrial Park Fuzhou, Jiangxi 344000 China.
Boya Bio-Pharmaceutical Group was founded in China.
In 2024, Boya Bio-Pharmaceutical Group is currently focus on Group Co Ltd sector.
Above is snippet of Google Trends for "Group Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Boya Bio-Pharmaceutical Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
